Share Search
Visit the Share Search
You are here:
Faron Pharmaceuticals Accounts Summary
| Date of Accounts | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Revenue | 1.31 | n/a | n/a | n/a | n/a |
| Operating Profit / Loss | -18.96 | -18.67 | -28.57 | -27.43 | -21.11 |
| Net Interest | -8.30 | -7.24 | -2.38 | -1.30 | -0.07 |
| Pre Tax Profit | -27.25 | -25.91 | -30.94 | -28.73 | -21.18 |
| Post Tax Profit | -27.26 | -25.92 | -30.94 | -28.73 | -21.19 |
| Profit for the Period | -27.26 | -25.92 | -30.94 | -28.73 | -21.19 |
| Equity Holders of Parent Company | -27.26 | -25.92 | -30.94 | -28.73 | -21.19 |
| Minority Interests | n/a | n/a | n/a | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | -25.77 EUX | -31.14 EUX | -51.54 EUX | -55.84 EUX | -45.10 EUX |
| Earnings per Share (Diluted) | -25.77 EUX | -31.14 EUX | -51.54 EUX | -55.84 EUX | -45.10 EUX |
| Earnings per Share (Adjusted) | -25.77 EUX | -31.14 EUX | -51.54 EUX | -55.84 EUX | -45.10 EUX |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -25.77 EUX | -31.14 EUX | -51.54 EUX | -55.84 EUX | -45.10 EUX |
| Earnings per Share (Diluted) | -25.77 EUX | -31.14 EUX | -51.54 EUX | -55.84 EUX | -45.10 EUX |
| Earnings per Share (Adjusted) | -25.77 EUX | -31.14 EUX | -51.54 EUX | -55.84 EUX | -45.10 EUX |
| Dividend per Share | n/a EUR | n/a EUR | n/a EUR | n/a EUR | n/a EUR |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Non-Current Assets | |||||
| Intangible Assets | 1.12 | 1.11 | 1.09 | 1.15 | 0.90 |
| Property, Plant and Equipment | 0.19 | 0.30 | 0.20 | 0.33 | 0.21 |
| Investments | n/a | n/a | n/a | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | 0.04 | 0.05 | 0.06 | 0.06 | 0.05 |
| Total Non-Current Assets | 1.35 | 1.46 | 1.35 | 1.54 | 1.16 |
| Current Assets | |||||
| Inventories | n/a | n/a | n/a | n/a | n/a |
| Trade and Other Receivables | 3.51 | 1.56 | 1.99 | 2.74 | 5.17 |
| Cash at Bank and in Hand | 12.32 | 9.50 | 6.88 | 6.99 | 6.85 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 15.83 | 11.07 | 8.87 | 9.73 | 12.02 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 17.17 | 12.52 | 10.22 | 11.27 | 13.18 |
| Current Liabilities | |||||
| Borrowings | 10.40 | 3.84 | 3.64 | 2.00 | 0.61 |
| Other Current Liabilities | 8.47 | 6.33 | 11.37 | 8.47 | 6.57 |
| Total Current Liabilities | 18.87 | 10.17 | 15.01 | 10.47 | 7.18 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | 14.28 | 8.27 | 9.47 | 11.27 | 2.93 |
| Provisions | n/a | n/a | n/a | 0.16 | n/a |
| Other Non-Current Liabilities | 2.53 | 3.84 | 0.90 | 0.85 | 0.15 |
| Total Non-Current Liabilities | 16.81 | 12.11 | 10.37 | 12.28 | 3.09 |
| Net Assets | -18.51 | -9.76 | -15.16 | -11.48 | 2.92 |
| Capital and Reserves | |||||
| Share Capital | 2.69 | 2.69 | 2.69 | 2.69 | 2.69 |
| Share Premium Account | n/a | n/a | n/a | n/a | n/a |
| Other Reserves | 201.66 | 184.97 | 154.36 | 129.55 | -116.28 |
| Retained Earnings | -222.86 | -197.42 | -172.21 | -143.71 | 116.51 |
| Shareholders Funds | -18.51 | -9.76 | -15.16 | -11.48 | 2.92 |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
| Total Equity | -18.51 | -9.76 | -15.16 | -11.48 | 2.92 |
| 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | |
| Operating Margin | -1,449.46% | n/a% | n/a% | n/a% | n/a% |
| Return on Capital Employed | -374.98% | -1,508.32% | 910.39% | -3,441.15% | -379.16% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | n/a | n/a | n/a | n/a | n/a |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | -0.08 EUR | -0.05 EUR | -0.07 EUR | -0.05 EUR | 0.01 EUR |